• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

偏向信号和别构机器:药物发现的新视野和新挑战。

Biased signalling and allosteric machines: new vistas and challenges for drug discovery.

机构信息

Department of Pharmacology, University of North Carolina, Chapel Hill, North Carolina, USA.

出版信息

Br J Pharmacol. 2012 Mar;165(6):1659-1669. doi: 10.1111/j.1476-5381.2011.01749.x.

DOI:10.1111/j.1476-5381.2011.01749.x
PMID:22023017
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3372820/
Abstract

Seven transmembrane receptors (7TMRs) are nature's prototype allosteric proteins made to bind molecules at one location to subsequently change their shape to affect the binding of another molecule at another location. This paper attempts to describe the divergent 7TMR behaviours (i.e. third party allostery, receptor oligomerization, biased agonism) observed in pharmacology in terms of a homogeneous group of allosteric behaviours. By considering the bodies involved as a vector defined by a modulator, conduit and guest, these activities can all be described by a simple model of functional allostery made up of the Ehlert allosteric model and the Black/Leff operational model. It will be shown how this model yields parameters that can be used to characterize the activity of any ligand or protein producing effect through allosteric interaction with a 7TMR.

摘要

七次跨膜受体(7TMRs)是自然界的变构蛋白原型,旨在结合一个位置的分子,随后改变其形状以影响另一个位置的另一个分子的结合。本文试图根据一组同质的变构行为来描述在药理学中观察到的不同的 7TMR 行为(即第三方变构作用、受体寡聚化、偏向激动作用)。通过将参与的主体视为由调节剂、导管和客体定义的向量,可以使用由 Ehlert 变构模型和 Black/Leff 操作模型组成的简单功能变构模型来描述这些活性。将展示如何使用该模型生成可用于表征任何通过与 7TMR 进行变构相互作用产生效应的配体或蛋白质的活性的参数。

相似文献

1
Biased signalling and allosteric machines: new vistas and challenges for drug discovery.偏向信号和别构机器:药物发现的新视野和新挑战。
Br J Pharmacol. 2012 Mar;165(6):1659-1669. doi: 10.1111/j.1476-5381.2011.01749.x.
2
Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.七跨膜受体作为构象变化蛋白:变构调节和功能选择性对新药发现的影响。
Pharmacol Rev. 2010 Jun;62(2):265-304. doi: 10.1124/pr.108.000992. Epub 2010 Apr 14.
3
G protein coupled receptors as allosteric proteins and the role of allosteric modulators.作为变构蛋白的G蛋白偶联受体及变构调节剂的作用。
J Recept Signal Transduct Res. 2010 Oct;30(5):313-21. doi: 10.3109/10799893.2010.503964.
4
The Quantitative Characterization of Functional Allosteric Effects.功能别构效应的定量表征
Curr Protoc Pharmacol. 2017 Mar 17;76:9.22.1-9.22.10. doi: 10.1002/cpph.18.
5
The plasticity of the 7TMR signaling machinery and the search for pharmacological selectivity.7TMR 信号机制的可塑性和寻找药理学选择性。
Curr Pharm Des. 2012;18(2):145-60. doi: 10.2174/138161212799040556.
6
Recent updates on GPCR biased agonism.G蛋白偶联受体偏向性激动作用的最新进展。
Pharmacol Res. 2016 Oct;112:49-57. doi: 10.1016/j.phrs.2016.01.031. Epub 2016 Feb 2.
7
Exploring the Technology Landscape of 7TMR Drug Signaling Profiling.探索 7TMR 药物信号分析的技术全景。
Curr Top Med Chem. 2015;15(24):2528-42. doi: 10.2174/1568026615666150701113344.
8
Biased ligand modulation of seven transmembrane receptors (7TMRs): functional implications for drug discovery.偏向性配体对七跨膜受体(7TMRs)的调节:对药物发现的功能影响。
J Med Chem. 2014 Aug 28;57(16):6887-96. doi: 10.1021/jm401677g. Epub 2014 Apr 29.
9
Synoptic pharmacology: Detecting and assessing the pharmacological significance of ligands for orphan receptors.概论药理学:检测和评估孤儿受体配体的药理学意义。
Pharmacol Res. 2016 Dec;114:284-290. doi: 10.1016/j.phrs.2016.01.022. Epub 2016 Jan 21.
10
Beta-arrestin-biased ligands at seven-transmembrane receptors.七跨膜受体上的β-抑制蛋白偏向性配体
Trends Pharmacol Sci. 2007 Aug;28(8):416-22. doi: 10.1016/j.tips.2007.06.006. Epub 2007 Jul 20.

引用本文的文献

1
Mu Opioid Receptor Positive Allosteric Modulator BMS-986122 Confers Agonist-Dependent G Protein Subtype Signaling Bias.μ阿片受体正向变构调节剂BMS-986122赋予激动剂依赖性G蛋白亚型信号偏向性。
Biochemistry. 2025 Jun 3;64(11):2376-2393. doi: 10.1021/acs.biochem.5c00022. Epub 2025 May 16.
2
Unraveling GPCRs Allosteric Modulation. Cannabinoid 1 Receptor as a Case Study.解析G蛋白偶联受体的变构调节。以大麻素1受体为例进行研究。
Proteins. 2025 Apr;93(4):763-785. doi: 10.1002/prot.26762. Epub 2024 Nov 25.
3
The cannabinoid CB receptor positive allosteric modulator EC21a exhibits complicated pharmacology .大麻素CB受体正向变构调节剂EC21a表现出复杂的药理学特性。
J Recept Signal Transduct Res. 2024 Aug;44(4):151-159. doi: 10.1080/10799893.2024.2431986. Epub 2024 Nov 22.
4
A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics.迷幻剂细胞神经生物学现状的综合综述
Biology (Basel). 2023 Oct 28;12(11):1380. doi: 10.3390/biology12111380.
5
A critical re-evaluation of the slope factor of the operational model of agonism: When to exponentiate operational efficacy.激动剂作用模式的斜率因子的关键性再评价:何时对作用效力取指数。
Sci Rep. 2023 Oct 16;13(1):17587. doi: 10.1038/s41598-023-45004-7.
6
Reconciling intrinsic properties of activating TNF receptors by native ligands versus synthetic agonists.通过天然配体与合成激动剂来协调激活 TNF 受体的固有特性。
Front Immunol. 2023 Sep 19;14:1236332. doi: 10.3389/fimmu.2023.1236332. eCollection 2023.
7
Exploring bias in platelet P2Y signalling: Host defence versus haemostasis.探讨血小板 P2Y 信号转导中的偏倚:宿主防御与止血。
Br J Pharmacol. 2024 Feb;181(4):580-592. doi: 10.1111/bph.16191. Epub 2023 Aug 2.
8
Advances in the allostery of angiotensin II type 1 receptor.血管紧张素II 1型受体别构调节的研究进展
Cell Biosci. 2023 Jun 17;13(1):110. doi: 10.1186/s13578-023-01063-x.
9
Allosteric modulation of gonadotropin receptors.促性腺激素受体的变构调节。
Front Endocrinol (Lausanne). 2023 May 25;14:1179079. doi: 10.3389/fendo.2023.1179079. eCollection 2023.
10
Pharmacological hallmarks of allostery at the M4 muscarinic receptor elucidated through structure and dynamics.通过结构和动力学研究揭示 M4 毒蕈碱受体变构作用的药理学特征。
Elife. 2023 May 30;12:e83477. doi: 10.7554/eLife.83477.

本文引用的文献

1
Impact of species variability and 'probe-dependence' on the detection and in vivo validation of allosteric modulation at the M4 muscarinic acetylcholine receptor.物种变异性和“探针依赖性”对 M4 毒蕈碱乙酰胆碱受体变构调节的检测和体内验证的影响。
Br J Pharmacol. 2011 Apr;162(7):1659-70. doi: 10.1111/j.1476-5381.2010.01184.x.
2
Functional selectivity and biased receptor signaling.功能选择性和偏向性受体信号转导。
J Pharmacol Exp Ther. 2011 Feb;336(2):296-302. doi: 10.1124/jpet.110.173948. Epub 2010 Oct 28.
3
Allosteric ligands of the glucagon-like peptide 1 receptor (GLP-1R) differentially modulate endogenous and exogenous peptide responses in a pathway-selective manner: implications for drug screening.胰高血糖素样肽 1 受体 (GLP-1R) 的变构配体以一种途径选择性的方式差异调节内源性和外源性肽的反应:对药物筛选的影响。
Mol Pharmacol. 2010 Sep;78(3):456-65. doi: 10.1124/mol.110.065664. Epub 2010 Jun 14.
4
Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.七跨膜受体作为构象变化蛋白:变构调节和功能选择性对新药发现的影响。
Pharmacol Rev. 2010 Jun;62(2):265-304. doi: 10.1124/pr.108.000992. Epub 2010 Apr 14.
5
The relative activity of "function sparing" HIV-1 entry inhibitors on viral entry and CCR5 internalization: is allosteric functional selectivity a valuable therapeutic property?“功能保留型”HIV-1进入抑制剂对病毒进入和CCR5内化的相对活性:变构功能选择性是否是一种有价值的治疗特性?
Mol Pharmacol. 2009 Mar;75(3):490-501. doi: 10.1124/mol.108.052555. Epub 2008 Dec 8.
6
On the fitting of binding data when receptor dimerization is suspected.当怀疑存在受体二聚化时结合数据的拟合
Br J Pharmacol. 2008 Sep;155(1):17-23. doi: 10.1038/bjp.2008.234. Epub 2008 Jun 9.
7
How and why do GPCRs dimerize?G蛋白偶联受体(GPCRs)如何以及为何会二聚化?
Trends Pharmacol Sci. 2008 May;29(5):234-40. doi: 10.1016/j.tips.2008.02.004. Epub 2008 Apr 1.
8
G-protein-coupled receptor heteromers: function and ligand pharmacology.G蛋白偶联受体异聚体:功能与配体药理学
Br J Pharmacol. 2008 Mar;153 Suppl 1(Suppl 1):S90-8. doi: 10.1038/sj.bjp.0707571. Epub 2007 Nov 26.
9
A day in the life of a G protein-coupled receptor: the contribution to function of G protein-coupled receptor dimerization.G蛋白偶联受体的一天:G蛋白偶联受体二聚化对其功能的贡献
Br J Pharmacol. 2008 Mar;153 Suppl 1(Suppl 1):S216-29. doi: 10.1038/sj.bjp.0707490. Epub 2007 Oct 29.
10
The role of GPCR dimerisation/oligomerisation in receptor signalling.G蛋白偶联受体二聚化/寡聚化在受体信号传导中的作用。
Ernst Schering Found Symp Proc. 2006(2):145-61. doi: 10.1007/2789_2006_007.